All Stories

  1. Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study
  2. Secondary Hyperparathyroidism in a Patient with CKD
  3. Sucroferric oxyhydroxide for the treatment of hyperphosphatemia
  4. Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease
  5. Chronic kidney disease-mineral and bone disorder
  6. Spectrum of bone pathologies in chronic kidney disease
  7. A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM)
  8. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism
  9. Clinical Skeletal Syndromes Associated with Parathyroid Disorders in Chronic Kidney Disease
  10. A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3-4 CKD
  11. Painful Skin Ulcers in a Hemodialysis Patient
  12. Rebuttal: PTH--A Particularly Tricky Hormone: Why Measure It at All in Kidney Patients?
  13. The Case for Routine Parathyroid Hormone Monitoring
  14. Renal osteodystrophy
  15. Chronic Kidney Disease-Mineral Bone Disorder
  16. Renal bone disease
  17. Use of vitamin D in chronic kidney disease patients
  18. Bone disease in renal transplant recipients
  19. Advances in renal bone disease: Osteoporosis and chronic kidney disease
  20. Bone Disease in Kidney Transplant Patients
  21. Aluminum: Its Measurement and Metabolism
  22. Bone Disease after Kidney Transplantation
  23. Bone Disease Following Kidney–Pancreas and Pancreas Transplantation
  24. Bone disease after kidney transplantation
  25. Use of vitamin D analogs in chronic renal failure
  26. Percutaneous bone biopsy in the diagnosis of renal osteodystrophy
  27. The Role of the Bone Biopsy in the Diagnosis of Renal Osteodystrophy
  28. Is β2-microglobulin a mediator of bone disease?
  29. Aluminum Neurotoxicity